Swedish life science demonstration laboratory
GE Healthcare has opened a key technology facility, the GE Healthcare Life Sciences Demonstration Laboratory, at the Science for Life Laboratory in Stockholm, Sweden.
GE Healthcare has opened a key technology facility, the GE Healthcare Life Sciences Demonstration Laboratory, at the Science for Life Laboratory (SciLifeLab) in Stockholm, Sweden. The laboratory, which is equipped with the company’s latest tools and technologies for life sciences research, plans joint research collaborations with SciLifeLab scientists as they seek to understand the latest challenges in human disease.
Mathias Uhlénd, director of SciLifeLab Stockholm, said, "Our vision for SciLifeLab is to create a world-leading centre for molecular biosciences and medical research to foster greater understanding of the nature of human diseases. GE’s Demonstration Laboratory will be a significant and positive addition to the SciLifeLab.”
"The SciLifeLab is assembling a world class multidisciplinary team to study some of medicine’s most pressing problems," said Peter Ehrenheim, retiring CEO of GE Healthcare Life Sciences. “We now know that many of the future advances in medicine will be driven by advances in our understanding of cellular mechanisms at the molecular level. GE Healthcare has a long history of innovation in life sciences, and we are committed to grow in partnership with our customers. The GE Healthcare Life Sciences Demonstration Laboratory will help us to do just that."
The laboratory is equipped with the company’s newest technologies for protein, cell biology and biomedical research. By helping the company gain a deeper understanding into the use of its technologies in a research environment, the laboratory also promises to help drive the future development of new innovations for life sciences research.
For more information about the company visit www.gehealthcare.com
Evaluating Antimicrobial Potential of Articaine Derivatives in Oral Infections with CMC
May 20th 2025Cell membrane chromatography (CMC) technology was used by researchers in screening efficacy and antibacterial ability of articaine (AT) derivatives in the pre-emptive treatment of oral infections.
Hydrophilic Interaction Chromatography (HILIC) and Direct Online Disruption of Lipid Nanoparticles
May 19th 2025Two proof-of-concept hydrophilic interaction chromatography HILIC) methods were developed in a joint study conducted by the University of Geneva (Switzerland), Sanofi, and the Waters Corporation—one for disrupting LNPs and retaining the mRNA, and another for detecting only unencapsulated mRNA to assess encapsulation efficiency. LCGC International spoke to Jonathan Maurer, first author of the paper that resulted from this study, about the methods and the efforts that led up to their development.
This article discusses how integrating seven prioritization strategies can enhance compound identification, support environmental risk assessment, and accelerate decision-making.
